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Willis KA, Siefker DT, Aziz MM, White CT, Mussarat N,
Gomes CK, Bajwa A, Pierre JF, Cormier SA, Talati AJ. Perinatal
maternal antibiotic exposure augments lung injury in offspring in
experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell
Mol Physiol 318: L407–L418, 2020. First published October 23,
2019; doi:10.1152/ajplung.00561.2018.—During the newborn period,
intestinal commensal bacteria influence pulmonary mucosal immu-
nology via the gut-lung axis. Epidemiological studies have linked
perinatal antibiotic exposure in human newborns to an increased risk
for bronchopulmonary dysplasia, but whether this effect is mediated
by the gut-lung axis is unknown. To explore antibiotic disruption of
the newborn gut-lung axis, we studied how perinatal maternal antibi-
otic exposure influenced lung injury in a hyperoxia-based mouse
model of bronchopulmonary dysplasia. We report that disruption of
intestinal commensal colonization during the perinatal period pro-
motes a more severe bronchopulmonary dysplasia phenotype charac-
terized by increased mortality and pulmonary fibrosis. Mechanisti-
cally, metagenomic shifts were associated with decreased IL-22
expression in bronchoalveolar lavage and were independent of hyper-
oxia-induced inflammasome activation. Collectively, these results
demonstrate a previously unrecognized influence of the gut-lung axis
during the development of neonatal lung injury, which could be
leveraged to ameliorate the most severe and persistent pulmonary
complication of preterm birth.
gut-lung axis; interleukin-22; microbiome; mucosal immunology;
pulmonary fibrosis
INTRODUCTION
Commensal microorganism ecology develops rapidly during
the newborn period (3). Emerging evidence suggests the mi-
crobial colonization of the intestine influences immune system
development and, by extension, alters inflammatory processes
(50). A critical window exists during the early neonatal period
where altered maturation of the microbiota can disrupt immune
development with profound consequences that may extend into
adulthood (4, 22). Moreover, gut-immune-lung crosstalk is
critical to lung disease (6, 34, 38, 49), and the intestinal
microbiome affects immune response at distal sites (12, 14, 28,
41, 48, 53). This interplay has been termed the ‘gut-lung axis’
(40), and it may provide a crucial influence on respiratory
function in early life.
Antibiotic administration has an intuitive and profound im-
pact on the microbiome (7). Unfortunately, preterm infants are
extensively exposed to antibiotics (23, 29). Although the ef-
fects of antibiotics are thought to be temporary in adults (18),
perinatal antibiotic exposure may have long-term effects on
organ development that remain largely unexplored (4, 22).
Intriguingly, antibiotic exposure is linked to increased risk
of developing bronchopulmonary dysplasia (BPD) (9, 46),
which remains the most serious and prevalent pulmonary
complication of preterm birth (33, 51). With growing evidence
for the importance of the gut-lung axis in BPD, one potential
explanation for this association is that microbial dysbiosis in
the neonatal period ultimately programs lung inflammation to
augment BPD pathogenesis.
To explore antibiotic disruption of the neonatal gut-lung
axis, we studied how maternal antibiotic exposure (MAE)
influenced lung injury in offspring in a hyperoxia-based mouse
model of BPD. Here, we show that disruption of intestinal
commensal communities by maternal antibiotic exposure pro-
moted a more severe phenotype of BPD characterized by
increased pulmonary fibrosis. Changes in lung architecture
secondary to alterations in neonatal microbial ecology were
independent of oxygen exposure-related inflammasome activa-
tion and associated with decreased IL-22 in bronchoalveolar
lavage. This work demonstrates a novel role for the gut-lung
axis in the pathogenesis of BPD.
METHODS
Animals. Specific pathogen-free C57BL/6J breeder mice were ob-
tained from The Jackson Laboratory (RRID:IMSR_JAX:000664, Bar
Harbor, ME) and housed in pathogen-free animal housing within the
pulmonary function facility at the University of Tennessee Health
Science Center (UTHSC; Memphis, TN). The Animal Care and Use
Address for reprint requests and other correspondence: K. A. Willis, The
Univ. of Tennessee Health Science Center, 853 Jefferson Ave., Room 201,
Memphis, TN 38163 (e-mail: kwill164@uthsc.edu).
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Committee approved all mouse protocols, and experiments were
conducted according to NIH guidelines. To clarify the effects of the
microbiome on lung injury, we used a standardized neonatal hyper-
oxia exposure-based mouse model of BPD (45), proceeded by alter-
ation of the maternal microbiome with antibiotics, to create a two-
exposure model of hyperoxia preceded by disruption of neonatal
commensal colonization. MAE was performed by administering pen-
icillin VK (500 mg/L) via the maternal drinking water (utilizing
average rates of consumption and bodyweight, this is approximately
0.08–0.1 mg·g1·day1) (13, 17). The dose was further clarified
using a series of pilot experiments with doses ranging from 5–500
mg/mL. Previous literature indicates a limited transfer of antibiotics
from dam to pup at these concentrations, with disruption of neonatal
colonization being the primary mechanism for alterations in the
neonatal microbiome of resulting offspring (13, 17, 43). Mice were
housed in ventilated cages with a filtered air supply and 12-h light-
dark cycle. After a period of cohousing to homogenize maternal
mouse microbiomes, we time-mated the mice to produce the maxi-
mum number of simultaneous birth cohorts. Pregnant dams were
randomized on gestational day 15 to either standard care or antibiotic
exposure. On the day of birth, pups from two consecutively born
litters with the same perinatal exposure were pooled and the pups
were distributed evenly between the two dams. Litter sizes for all
experiments were adjusted to 5–8 pups per treatment group to mini-
mize nutritional effects on lung development. One pooled litter was
assigned to hyperoxia [fraction of inspired oxygen (FIO2) 0.60 or 0.8])
and the other to air (FIO2 0.21). Pups were exposed continuously for 14
days in a Plexiglass chamber (Cleatech, Santa Ana, CA) starting on
the day after birth. Oxygen concentrations were maintained using a
ProOx monitor (Biospherix, Rockfield, NY). Dams were rotated daily
between the two pooled litters to limit the complications of hyperoxia.
For neonatal lungs not used for histology, we calculated the lung-to-
body weight ratio and monitored growth of the pups throughout the
experiment. To further clarify the critical exposure period, we per-
formed a crossover experiment. Starting with two MAE litters and two
nonexposed litters per treatment arm, we cross-fostered the pups at
delivery: pups that were prenatally exposed (preMAE) were fostered
to dams with an intact microbiome, and unexposed pups were fostered
to exposed dams so that the pups were postnatally exposed (post-
MAE). Neonatal mice were examined for sex at the end of each
experiment and tail snips saved for genetic confirmation.
Lung morphometric analysis. To quantify the effects of lung injury,
we performed morphometric analysis using histologic sections of
whole lung. After exposure to hyperoxia or air, pups were weighed
and euthanized for tissue harvest. The lungs of each animal were
gravity inflated with zinc formalin. Three random sections from the
lungs of each animal were stained with hematoxylin and eosin with
the assistance of Drs. Balazs and Seagroves at the UTHSC Research
Histology Core. Lung sections from each experiment were digitized
under 20 magnification and analyzed independently by two opera-
tors blinded to the group assignments. Images were captured using an
EVOS FL Auto microscope (Thermo Fisher Scientific, Rockford, IL).
Alveolarization was quantified using the mean linear intercept (Lm),
weighted averages of the alveolar area (D1, D2), and mean septal
thickness. D1 and D2 were calculated using a Python script, which was
the kind gift of James Carson (32) (available at: https://github.com/
jamescarson3/computeD2). Manual calculations of the Lm were ver-
ified against a semiautomated method using FIJI (42). To quantify
pulmonary fibrosis, Masson trichrome staining of slides from three
pups/group was performed by the UTHSC Research Histology Core.
Five representative images were obtained at 20 from each slide and
analyzed by two operators blinded to the group assignments using a
pathology score validated to quantify hyperoxia exposure-related lung
injury in the mouse (31) and a pseudocolorimetric image analysis
technique to quantify the amount of green-stained collagen fibers in
Masson trichrome stained tissue (11).
Immunohistochemistry. To further explore compositional changes
in the interalveolar septa, representative slides were cut from paraffin-
embedded samples. Three slides per group were deparaffinized and
rehydrated with graduated concentrations of ethanol, underwent anti-
gen retrieval with 10 M Sodium Citrate Buffer with 20% Tween,
were blocked in blocking buffer (1% horse serum BSA) for 30 min,
and were incubated overnight with primary antibodies (described
below) at 2–8°C in incubation buffer (1% BSA, 1% normal donkey
serum, 0.3% Triton X-100, and 0.01% sodium azide in PBS) prepared
according to the manufacturer’s instructions. The next day they were
washed again in PBS, fenestrated, blocked with Mouse BD Fc Block
(Clone 2.4G2, cat. no. 553142, RRID: AB_394657, BD Biosciences),
and then counterstained with ProLong Diamond Anti-Fade Mounting
Media with DAPI (4=,6-diamidino-2-phenylindole; cat. no. P36962,
RRID:AB_2307445, Thermo Fisher Scientific). Images were then
captured using an Eclipse Ti2-E inverted microscope system (Nikon,
Tokyo, Japan). Primary antibodies included the following: APC rat
anti-mouse CD45 (Clone 30-F11, lot no. 4271830, cat. no. 561018,
RRID:AB_10584326, BD Biosciences) and mouse monoclonal anti-
smooth muscle actin (SMA) Cy3 antibody (Clone 1A4, lot no.
059M4797V, cat. no. C6198, RRID: AB_476856, Sigma-Aldrich).
Representative images were then captured at 20 magnification. We
also prepared additional slides using the myeloperoxidase polyclonal
antibody (cat. no. PA5-16672, RRID:AB_11006367, Thermo Fisher
Scientific).
Vascular density. In addition to quantifying capillaries with a
diameter less than 50 m stained with SMA, to further quantify
vascular density, we used a polyclonal antibody of anti-von Wille-
brand Factor (vWF) (cat. no. ab6994, RRID:AB_305689, Abcam).
Five representative images at 20 were captured on an EVOS FL
Auto microscope (Thermo Fisher Scientific, Rockford, IL) using
systematic random sampling. To quantify vascular density, we
counted the number of vWF-positive vessels (both venules and
capillaries) with a diameter less than 50 m per 20 high-power field
using an established method (10).
Inflammasome activity. We assessed inflammasome activity using a
caspase-1 bioluminescent assay kit prepared according to the manu-
facturer’s instructions from a whole lung homogenate of three mice
per group. Samples were initially snap-frozen and stored at 80°C at
the termination of each experiment (Caspase-Glo 1 Inflammasome
Assay, cat. no. G9951, Promega, Madison, WI).
Microbiota depletion and 16S microbial community analysis. To
study the influence of commensal ecological diversity, we depleted
the intestinal microbiota by exposing pregnant dams to penicillin (500
mg/L) via the drinking water ad libitum starting on gestational day 15.
Antibiotic administration to the dam was continued throughout the
exposure period to hyperoxia or air. The entire colonic contents were
collected from the resulting offspring at the termination of each
experiment (postnatal day 15, P15) and snap frozen in liquid nitrogen
before being stored at 80°C. Intestinal contents were resuspended in
500 L of TNES buffer containing 200 units of lyticase and 100 L
of 0.1/0.5 (50/50 Vol.) virconia beads. Samples were incubated for 20
min at 37°C before 2  1 min of ultra-high-speed bead beating. After
mechanical disruption, 20 g of proteinase K were added to all
samples. Samples were incubated overnight at 55°C with agitation.
The following day, total DNA was extracted with the chloroform
isoamyl alcohol method. Total DNA concentration per mg stool was
determined by qRT-PCR. DNA samples were sent to the Argonne
National Laboratory (Lemont, IL) for 16S metagenomic barcoding
using the NextGen Illumina MiSeq platform. Blank samples passed
through the entire collection, extraction, and amplification process did
not produce any DNA amplification. Microbial genomic DNA was
isolated, and the variable 4 region of the 16S rRNA gene was
amplified using unique barcoded primers. Sequence data were pro-
cessed and analyzed using QIIME 1.9.1. The data were then imported
into Calypso 8 for further analysis and visualization. Samples were
normalized using the Hellinger Transformation (square root of total
L408 MATERNAL ANTIBIOTIC EXPOSURE AUGMENTS BPD
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00561.2018 • www.ajplung.org
Downloaded from journals.physiology.org/journal/ajplung at LSU Louisiana State Univ (130.039.060.164) on August 10, 2021.
sum normalization). The Shannon Diversity Index was used to quan-
tify alpha diversity (intersample). Structured principal coordinates
analysis (PCoA) of Bray–Curtis dissimilarity matrices, nonmetric
multidimensional scaling, and unstructured redundancy analysis
(RDA) were used to analyze beta diversity. Permutational multivariate
analysis of variance (PERMANOVA) with 999 permutations was
used to assess statistical significance of the PCoA. To quantify relative
abundance of taxa between groups, we utilized either the Kruskal–
Wallis test or one-way ANOVA adjusted for false discovery. Network
analysis was performed using Spearman’s correlations with positive
false-discovery-rate adjusted P values  0.05 displayed as an edge.
Characterization of bronchoalveolar lavage. To quantify altera-
tions in lung cytokine levels, we isolated bronchoalveolar lavage
(BAL) fluid with 0.3 mL of PBS and 0.5% BSA. BAL was used in the
Milliplex Map Mouse Cytokine/Chemokine Magnetic Bead assay
(cat. no. MCYTOMAG-70K-PMX, Millipore Sigma, Billerica, MA)
for TNF, IL-1, IL-6, IL-17A, and IL-22. Samples were incubated
overnight at 4°C and analyzed using a Luminex 200 SD System
(EMD Millipore, Burlington, MA).
Statistical analysis. For each analysis, the data presented are from
two to three pooled experiments with five to eight pups per group in
each experiment. Data are presented as means  SE. Where indicated,
data are further expressed as fold changes relative to air controls or as
median  interquartile range. The effects of microbiome depletion
and hyperoxia exposure were tested by two-way ANOVA (Prism
v8.2, GraphPad Software, La Jolla, CA). For nonparametric data, the
Friedman rank sum test was run in R using the “stats” package (46a).
Variables were considered significant with a false-discovery adjusted
P  0.05.
RESULTS
Microbial colonization by commensal bacteria promotes resis-
tance to lung injury in neonatal mice. Maternal and frequent
direct postnatal antibiotic exposure have been linked to alter-
ations of the intestinal microbiome in human newborns and
an increased risk later in life for immune-mediated pulmo-
nary conditions such as asthma and pneumonia (20). This
led us to hypothesize that perinatal exposure to commensal
bacteria would promote resistance to lung injury in preterm
newborns. To test this hypothesis, we exposed pregnant
mouse dams that had initially been cohoused to homogenize
their microbial colonization to the most commonly used
perinatal antibiotic, penicillin (23, 29), starting on the tenth
day of gestation. We then studied the colonic microbiota of
the pups and changes in their lung architecture at 15 days of
life (Fig. 1A).
Under undisrupted development, the intestinal commensal
bacterial load of newborn pups expands markedly after birth.
By 15 days of life, MAE disrupted commensal colonization,
as quantified by the absolute number of bacteria to levels
observed in 5-day-old unexposed mice (one-way ANOVA,
P 	 0.0374; Fig. 1B) and produced marked shifts in the
bacterial colonization pattern (Fig. 1 and Supplemental Fig. S1;
all Supplemental Material is available at https://doi.org/
10.6084/m9.figshare.9891209) and the predicted metagenome
(Supplemental Fig. S2 and Supplemental Table S1). MAE also
altered the median alpha diversity (Shannon Diversity Index,
one-way ANOVA, f 	 4.1, P 	 0.0019; Supplemental Fig.
S1D) and led to significant shifts in the beta diversity (PCoA
PERMANOVA with 999 permutations of Bray–Curtis dissim-
ilarity, R2 	 0.302, P 	 0.00033; Fig. 1C and unstructured
RDA, variance 87.29, f 	 8.46, P 	 0.001; Fig. 1D). At the
phylum level, the most prominent shift related to MAE was in
Firmicutes, with combinatory effects of hyperoxia exposure
and MAE resulting in shifts in Verrucomicrobia, Tenericutes,
and Actinobacteria (Fig. 1E). Overall, the most significant
changes were reduced abundance of the order Erysipelo-
trichales and the genus Lactobacillus, leading to an expansion
in the family Peptostreptococcacea and genus Anaerofustis
(Supplemental Fig. S3A). MAE also altered the predicted
metagenome (Supplemental Table S1). Network analysis fur-
ther supports the influence of MAE on multiple bacteria genera
(Fig. 1F). Alterations in the microbial colonization pattern are
enhanced by hyperoxia exposure (Fig. 1), but, importantly,
colonization of the neonatal gut was not significantly altered by
exposure to hyperoxia alone (Supplemental Fig. S4).
To explore how commensal colonization influenced neona-
tal hyperoxia-based lung injury, we used morphometry of lung
histology to compare changes in lung architecture between
neonatal pups born after MAE to age-matched, unexposed
controls (Fig. 2). At baseline, the Lm and septal thickness of
MAE-negative controls is consistent with the established liter-
ature at FIO2 0.21, 0.60, and 0.85 (45). In general, MAE alone
increased the mean septal thickness and the Lm but did not
significantly alter alveolar heterogeneity (D1 and D2, Fig. 2B).
However, in combination with hyperoxia exposure, MAE pro-
duced characteristic changes that increased the septal thickness
and the Lm but produced only an interactive effect on alveolar
area heterogeneity (Fig. 2B). No effect of sex was appreciated
on the Lm, septal thickness, or alveolar heterogeneity (three-
way ANOVAs, NS for sex). Taken together, these results
suggest that MAE disrupts neonatal intestinal colonization,
potentiates alveolar simplification, and increases septal thick-
ness after hyperoxia exposure.
Increasing oxygen concentration potentiates maternal anti-
biotic exposure-induced alterations in lung architecture. To
explore how dose-dependent changes in oxygen exposure al-
tered lung architecture after MAE, we exposed newborn pups
to two different concentrations of hyperoxia: FIO2 0.60 and
0.85. As the concentration of oxygen increased, a combinatory
increase in the Lm and septal thickness but not alveolar area
heterogeneity was noted (Fig. 2B). We did not observe an
effect of sex as a biological variable. Overall, these results
suggest that increasing oxygen exposure potentiates enlarge-
ment of the interalveolar septa driven by MAE. Increased
septal thickness contributes to clinical morbidity by increasing
the diffusion distance, suggesting that in combination with
MAE hyperoxia increased the severity of BPD.
Lung injury following maternal antibiotic exposure is
characterized by increased pulmonary fibrosis. To determine
whether increased septal thickness following MAE primarily
represented pulmonary fibrosis, we assessed collagen deposi-
tion using a pathology score (31) and an image analysis
technique (11). In conjunction with what has been previously
described (16), exposure to hyperoxia increased pulmonary
fibrosis. MAE, however, potentiated the formation of fibrosis,
as quantified by an increase in the median pathology score,
both in combination with normoxia and to a greater extent in
combination with hyperoxia (Friedman rank sum test, P 
0.0001; Fig. 3A). We supported these findings by quantifying
collagen deposition in a subset of samples using image analysis
and noted that MAE led to a higher relative density of collagen
fibers (two-way ANOVA interaction, NS; MAE, P  0.0001;
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hyperoxia, NS; Supplemental Fig. S5A). Together, these data
provide evidence that disruption of commensal colonization
produces altered lung architecture characterized by increased
pulmonary fibrosis.
Maternal antibiotic exposure increases CD45-postive cells
and granulocytes. MAE increased the number of CD45-posi-
tive cells in the interalveolar septa (two-way ANOVA interac-
tion and hyperoxia, NS; MAE, P  0.001; Fig. 3B). In the
combined exposure, SMA-positive cells can also be ob-
served, further providing additional evidence for increased
early fibrotic changes produced by the combined exposure.
Similarly, MAE also increased granulocytic infiltration in com-
bination with both room air and hyperoxia, as quantified by the
percentage of myeloperoxidase positive nuclei (two-way
ANOVA interaction, NS; MAE, P 	 0.0002, hyperoxia expo-
sure, NS; Supplemental Fig. S6A). Together, these results show
potentiation of immune infiltration after MAE, suggesting that
in addition to altering lung architecture, immune-mediated
processes may play a role in lung injury after commensal
disruption.
Maternal antibiotic exposure potentiates hyperoxia-induced
pulmonary vascular remodeling. MAE significantly reduced
the density of pulmonary capillaries (SMA-positive muscu-
larized vessels with a diameter less than 50 m per high-power
field; two-way ANOVA interaction, P 	 0.00; MAE and
hyperoxia, P  0.001; Fig. 3, B and C; Supplemental Fig.
S6B). Additionally, MAE significantly decreased the density of
all vessels as quantified by vWF-positive vessels with a diam-
eter 50 m per high-power field (two-way ANOVA interac-
tion and MAE, P  0.0001; hyperoxia, P 	 0.0002; Supple-
mental Fig. S6C). This finding demonstrates that changes in
lung architecture after commensal community disruption dra-
matically reduces pulmonary vasculature crucial for functional
gas exchange in our model. Reduced vascular density and subse-
Fig. 1. Maternal antibiotic exposure induces
a characteristic commensal disruption of
the neonatal gut microbiome at 15 days of
life. A: experimental schema. C57Bl/6J mice
were cohoused to normalize the microbiome
and then time-mated to produce multiple
simultaneous litters exposed to either mater-
nal antibiotic exposure (MAE) or purified
water (controls). After birth, neonatal mice
were exposed to either normoxia (air) or
hyperoxia for 14 days. Neonatal mice were
humanely euthanized for stool and tissue
collection at 15 days of life. E15, embryonic
day 15; P15, postnatal day 15. B: as quanti-
fied by qRT-PCR, MAE reduced the abso-
lute abundance of the bacterial 16S rRNA
gene in the neonatal colon at 15 days to a
level similar to a specific pathogen-free
5-day-old pup (one-way ANOVA, P 	
0.0374). C: structured principal coordinates
analysis [PCoA, permutational multivariate
ANOVA (PERMANOVA) with 999 permu-
tations of Bray–Curtis dissimilarity, R2 	
0.302, P 	 0.00033]. D: unstructured redun-
dancy analysis (RDA, variance 87.29, f 	
8.46, P 	 0.001). C and D demonstrate that
the composition of the neonatal colonic mi-
crobiome at 15 days of life differs by expo-
sure to MAE and not hyperoxia. Centroids
added for emphasis. E: differences in relative
abundance at the phylum level. Sqrt(TSS),
square root total sum normalization (Hell-
inger Transformation). F: Spearman network
analysis. Positive correlations with false dis-
covery rate-adjusted P values  0.05 are
displayed as an edge, and relative size rep-
resents significance of the edge to the sur-
rounding network. n 	 5–8 pups/group in 3
independent experiments; data points repre-
sent individual animals. One-way ANOVA,
Bonferroni, *P  0.05, **P  0.01, ***P 
0.001. FIO2, fraction of inspired oxygen; P0,
day of birth.
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Fig. 2. Commensal disruption produces a more severe phenotype of bronchopulmonary dysplasia. A: representative micrographs of hematoxylin and eosin-stained
lung sections that were gravity inflation-fixed from 15-day-old neonatal mice exposed to either normoxia (air) (Aa), maternal antibiotic exposure (MAE) and
normoxia (Ab), fraction of inspired oxygen (FIO2) 0.60 (Ac), MAE and FIO2 0.60 (Ad), FIO2 0.85 (Ae), or MAE and FIO2 0.85 (Af). Scale bars represent 200 m.
B: septal thickness, two-way ANOVA interaction, MAE and hyperoxia, P  0.001. C: mean linear intercept, two-way ANOVA interaction not significant (NS),
MAE, P 	 0.0004; hyperoxia, P  0.001. D and E: airway heterogeneity (weighted means of airway diameter, D1 and D2) demonstrates only an interactive effect
of MAE (two-way ANOVA interaction, P  0.0001; MAE NS, hyperoxia, P  0.0001); n 	 5–8 pups/group in 3 independent experiments; data points represent
individual animals and error bars display mean  SE.
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quent pulmonary hypertension are important causes of in-
creased mortality in BPD (1) and may have significant impli-
cations for the clinical care of newborns extensively exposed to
antibiotics.
Maternal antibiotic exposure leads to increased mortality.
We monitored survival until the predetermined end point of the
experiments. At all timepoints, MAE produced an imprecise
trend toward increased mortality (Fig. 4A). However, in com-
bination with FIO2 0.85, MAE significantly increased mortality
over hyperoxia alone (log-rank test, P 	 0.002). Hyperoxia
alone did not produce a significant increase in mortality. Two
distinct phases of mortality can also be appreciated. While
earlier mortality during the first several days is less clearly
linked to the combined exposure and may represent mortality
from hyperoxia exposure, later mortality clearly increased with
the combined exposure. These results suggest that commensal
disruption potentiates mortality during the development of
hyperoxia exposure-based lung injury. Additionally, this
model is limited by the fact that severely diseased pups may
succumb to the exposure because they are not mechanically
ventilated. Unfortunately, these mice are not suitable for in-
clusion in further experimentation, which could produce a
survival bias. A survival advantage for mice with intact com-
mensal ecologies may suggest that our demonstration of in-
Fig. 3. Commensal disruption increases fibrosis and immune cell recruitment and decreases vascular density. a–d: for each group of representative micrographs:
normoxia alone (a), maternal antibiotic exposure (MAE) alone (b), hyperoxia exposure at fraction of inspired oxygen (FIO2) 0.85 alone (c), and the combined
exposure of MAE and hyperoxia (d). A: Masson trichrome staining with data presented as median  interquartile range of a pathology score (Ae) (Friedman rank
sum test, P  0.0001). Black scale bars represent 200 m. Data points represent individual animals; n 	 3–5 pups/group in 3 independent experiments. B:
representative immunohistochemistry for CD45 (Cy5, pseudocolored green channel) and -smooth muscle actin (SMA, red channel). C: quantification of the
percentage of CD45-positive cells (two-way ANOVA interaction and hyperoxia exposure not significant; MAE, P  0.001). D: quantification of the number of
SMA-positive vessels 50 m in diameter per 20 microscopic field (two-way ANOVA interaction, P 	 0.001; hyperoxia exposure and MAE, P  0.001).
White scale bar represents 100 m. n 	 3–5 pups/group; data points represent individual animals, and error bars display mean  SE.
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creased severity of lung injury after MAE underestimates the
overall severity of lung injury resulting from commensal dis-
ruption.
Maternal antibiotic exposure influences neonatal growth.
Antibiotic exposure has a well-described effect on growth in
animals (13, 17). In our hands, MAE did not produce a
significant difference in the lung-to-body weight ratio in neo-
natal mice at 15 days of life (Supplemental Fig. S7, A and B).
However, MAE did lead to a dose-dependent effect on total
body mass of the offspring by 15 days of life (one-way
ANOVA, P 	 0.004; Supplemental Fig. S5C). This effect was
partially countered by exposure to hyperoxia, which produced
a wasting effect on total body mass (two-way ANOVA, P 	
0.0053; Supplemental Fig. S7C).
Hyperoxia-induced inflammasome activation is not altered
by maternal antibiotic exposure. Because the NLRP3 inflam-
masome is a critical component of canonical lung injury in
BPD (39), we assessed inflammasome activity in lung tissue
and noted inflammasome activation was increased by hyper-
oxia (two-way ANOVA, P  0.001; Fig. 4B); however, no
difference was detected with the addition of MAE [nonsignif-
icant (NS)]. Considered in conjunction with cytokine differ-
ences noted in BAL, these results suggest that a different
mechanism may be responsible for changes in lung architecture
after commensal disruption than has been described for hyper-
oxia alone.
Maternal antibiotic exposure produces differences in cyto-
kine abundance in bronchoalveolar lavage. BPD is associated
with increased levels of IL-6 and IL-1 and lower concentra-
tions of IL-17A in BAL (2). In particular, IL-1 has recently
been expressed in a monocyte-dependent manner (19) and
associated with long-term lung injury (27). The IL-17 family is
also important as cytokines that link microbial signaling with
lung physiology (24). Although BAL concentrations of IL-22
are undescribed in BPD, decreased IL-22 levels in BAL have
been associated with impaired lung mucosal immune function
in a neonatal mouse model of pneumonia (22). To characterize
cytokine differences, we collected BAL at 15 days of life for
multiplex cytokine evaluation. MAE decreased IL-17A (two-way
ANOVA interaction and hyperoxia, NS; MAE, P 	 0.0005; Fig.
4B) and IL-22 in neonatal offspring (two-way ANOVA interac-
tion and hyperoxia, NS; MAE, P 	 0.0042; Fig. 4C). IL-6 and
Fig. 4. Commensal disruption increases mortality and produces changes in some bronchoalveolar lavage (BAL) cytokine levels. A: maternal antibiotic exposure
(MAE) leads to increased mortality during hyperoxia exposure [fraction of inspired oxygen (FIO2) 0.85 compared with MAE and FIO2 0.85, log-rank test, P 	
0.002]. Normoxia (black), intermediate hyperoxia (blue), and elevated hyperoxia (red), with MAE exposure indicated by a dotted line. B: inflammasome activity
is increased by hyperoxia but not by the addition of MAE [two-way ANOVA hyperoxia exposure, P  0.0001; MAE, not significant (NS)]. C: low-level BAL
cytokine concentrations with a limited effect of MAE but not hyperoxia (IL-22: two-way ANOVA interaction, NS; MAE, P 	 0.0042; hyperoxia exposure, NS;
IL-17A: two-way ANOVA interaction, NS; MAE, P 	 0.005; hyperoxia exposure, NS; IL-6: two-way ANOVA interaction, NS; MAE, P 	 0.0217; hyperoxia
exposure, NS; TNF-: two-way ANOVA interaction, NS; MAE, P 	 0.0396; hyperoxia exposure, NS). Except where noted, error bars represent mean  SE;
n 	 7–20 pups/group; data points represent individual animals. Significance was determined by two-way ANOVA, and P  0.05 was considered significant.
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TNF were also reduced by antibiotic exposure (IL-6: two-way
ANOVA interaction and hyperoxia, NS; MAE, P 	 0.0217;
TNF: two-way ANOVA interaction and hyperoxia, NS; MAE,
P 	 0.0396). IL-1 was underpowered due to several samples
falling below the detection threshold (Supplemental Fig. S5B).
These results could suggest that intestinal commensal disruption
produces modest reductions in cytokines associated with micro-
bial signaling (IL-22 and IL-17A), as well as altering cytokine
production associated more traditionally with hyperoxia (IL-6 and
TNF) at this time point.
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Prenatal maternal antibiotic exposure produces more fi-
brotic changes than postnatal exposure. To further clarify the
critical exposure period, we performed a crossover experi-
ment (Fig. 5). PreMAE produced a higher grade of fibrosis
than postMAE did (Friedman rank sum test, P 	 0.00016;
Fig. 5B) at both normoxia (Wilcoxon, P 	 0.0001) and in
combination with exposure to hyperoxia (FIO2 0.85; Wil-
coxon, P 	 0.002). Correspondingly, preMAE also pro-
duced more significant thickening of the interalveolar septa
(two-way ANOVA interaction, NS; antibiotics, P 	 0.0013;
hyperoxia, P  0.0001; Fig. 5D). However, postMAE led to
increases in the Lm (two-way ANOVA interaction, NS;
antibiotics, P 	 0.0013; hyperoxia, P  0.0001), D1 (two-
way ANOVA interaction, P 	 0.0002; antibiotics, P 	
0.0003; hyperoxia, P  0.0001), and D2 (two-way ANOVA
interaction, P  0.0001; antibiotics, P 	 0.0002; hyperoxia,
P  0.0001; Fig. 5D). No differences in the Lm, septal
thickness or alveolar heterogeneity were noted with the sex
of the pups (three-way ANOVA, NS). In comparison with
the first experiment, preMAE likely contributes more to the
increased septal thickness observed from the combined
prenatal and postnatal MAE (one-way ANOVA, P  0.001;
Supplemental Fig. S8A), while postMAE more robustly
altered D1 and D2 (one-way ANOVA, P  0.0001; Supple-
mental Fig. S8C and one-way ANOVA, P  0.0001; Sup-
plemental Fig. S8D, respectively) and increased the Lm
(one-way ANOVA, P 	 0.0276; Supplemental Fig. S8E).
Furthermore, although both preMAE and postMAE alter
both CD45-positive cell infiltration and capillary density as
compared with unexposed mice, no significant differences
were observed between preMAE and postMAE in this lim-
ited sample (two-way ANOVA, NS; Fig. 6). Considered
together, these findings suggest that prenatal exposure may
lead to greater fibrosis during later hyperoxia exposure, but
postnatal exposure may potentiate lung injury from hyper-
oxia.
Fig. 5. Prenatal exposure to maternal antibiotics enhances fibrosis, while postnatal exposure accentuates changes in lung architecture from hyperoxia exposure.
A: experimental schema showing the birth of simultaneous litters to either purified water- or antibiotic-exposed dams. The resulting offspring were then fostered
to dams in the opposite study arm at birth, before exposure to hyperoxia or normoxia, producing prenatal maternal antibiotic-exposed (preMAE, red) and postnatal
maternal antibiotic-exposed (postMAE, blue) cohorts. B: preMAE enhances fibrosis (Friedman rank sum test, P 	 0.00016). C: representative micrographs of
hematoxylin and eosin-stained lung sections that were gravity inflation-fixed from 15-day-old neonatal mice exposed to either preMAE and normoxia (air, a),
preMAE and fraction of inspired oxygen (FIO2) 0.85 (b), postMAE and normoxia (c), or postMAE and FIO2 0.85 (d). D: septal thickness (two-way ANOVA
interaction, P 	 0.0092; antibiotics and hyperoxia, P  0.0001) is increased in preMAE, but the mean linear intercept (two-way ANOVA interaction, not
significant; antibiotics, P 	 0.0013; hyperoxia, P  0.0001) and weighted means of airway diameter (D1: two-way ANOVA interaction, P 	 0.0002; antibiotics,
P 	 0.0003; hyperoxia, P  0.0001 and D2: two-way ANOVA interaction, P  0.0001; antibiotics, P 	 0.0002; hyperoxia, P  0.0001) are increased in
postMAE. n 	 5–8 pups/group in 2 independent experiments; datapoints represent individual animals, and error bars represent mean  SE. E15, embryonic day
15; P0, day of birth; P15, postnatal day 15.
Fig. 6. Prenatal and postnatal maternal antibiotic exposure produce equivalent alterations in pulmonary immune cell recruitment and vascular density. A:
representative micrographs for CD45 (Cy5, pseudocolored green channel) and -smooth muscle actin (SMA, red channel). a: prenatal maternal antibiotic
exposure (preMAE) at normoxia (air). b: postnatal maternal antibiotic exposure (postMAE) at normoxia. c: preMAE at fraction of inspired oxygen (FIO2) 0.85.
d: postMAE at FIO2 0.85. B: quantification of the percentage of CD45-positive cells [two-way ANOVA, not significant (NS)]. C: quantification of the number
of SMA-positive vessels 50 m in diameter per 20 microscopic field (two-way ANOVA, NS). White scale bar represents 100 m. n 	 3–5 pups/group;
datapoints represent individual animals, and error bars display mean  SE.
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DISCUSSION
The intestinal microbiota have the capacity to exert distal
effects on the host. This appears to be most relevant during the
neonatal period, where it has been proposed that disruption of
early commensal colonization of the intestine may produce
long-lasting alterations in host metabolic and immune set-
points. Recent evidence suggests that intestinal commensals
can influence the lungs (22, 47), a phenomenon called the
gut-lung axis (26). However, the mechanisms by which intes-
tinal dysbiosis alters the progression of lung injury and disease
remain poorly understood.
Our findings provide evidence that MAE, likely mediated by
alterations in intestinal commensal bacteria, can augment the
development of lung injury during neonatal life. Early-life
antibiotic-associated disruption of intestinal colonization has
been associated with increased severity of allergic and infec-
tious lung disease (4, 22), but a role for intestinal commensals
in the propagation of lung injury has not been previously
demonstrated. We selected BPD as our model system because
this disease is the most severe form of newborn lung injury and
affects about half of infants born before 28 wk of gestation
(51). Furthermore, antibiotic use has been associated with an
increased risk of developing BPD in retrospective human
cohort studies (4, 22). Because the majority of the microbiome
is transferred vertically from mother to offspring (21, 44), we
focused on maternal rather than direct exposure to the new-
born, as this would allow us to most clearly interrogate the role
of early-life colonization. We disrupted neonatal commensal
colonization with MAE and profiled how disturbed coloniza-
tion in the resulting pups altered the development of BPD in
these neonatal animals. These experiments showed commensal
disruption increased mortality and alteration of pulmonary
architecture during exposure to hyperoxia-induced lung injury,
characterized by augmented fibrosis, cellular proliferation, and
neutrophilic infiltration. Because of the high prevalence of both
antibiotic exposure and BPD in preterm newborns, translation
to clinical practice may involve reduction in antibiotic admin-
istration in the short term and microbiome-altering therapeutics
in the future. Furthermore, we noted that preMAE contributed
to the formation of hyperoxia-induced fibrosis even when pups
were reared with dams with an intact microbiota after birth. In
contrast, the postMAE in pups born to dams with intact
commensal ecology contributed to hyperoxia exposure-in-
duced lung injury, suggesting that perinatal MAE alters lung
injury and that the effects may vary depending on the timing of
exposure.
As evidence of the importance for the microbiome in im-
mune and pulmonary development has increased, considerable
interest has arisen in the role of the microbiome in the devel-
opment of BPD. However, the focus to date has been on the
airway microbiome. The gut microbiota may exhibit a wide
range of extraintestinal effects, as highlighted by alterations in
pulmonary development and body weight in our model. A
recent systematic review was able to identify six studies of the
airway microbiome, but none that explored the intestinal mi-
crobiome in BPD. Unfortunately, these studies also had sig-
nificant heterogeneity in methodologic approaches and clinical
characteristics, which makes drawing more systematic conclu-
sions difficult. Moreover, although differences in the airway
microbiome are beginning to be understood in BPD (37), only
one study has examined the gut microbiome in BPD (8). This
cohort showed that fecal volatile organic compounds, poten-
tially arising from metabolites produced by intestinal commen-
sals, predicted which infants would develop BPD. However,
when these authors attempted to demonstrate differences in the
intestinal microbiome at 28 days of life, they were unable to
detect a difference (8). Taken together, these studies demon-
strate that while differences in the airway microbiome may
result during the development of BPD, the role of the intestinal
microbiome is still unknown. Our study provides valuable
experimental evidence that manipulation of the gut microbiota
by antibiotic exposure influences the progression of lung in-
jury. While there are significant differences between the mouse
and human microbiome, our work provides mechanistic in-
sights that may assist in the interpretation of future observa-
tional studies in human newborns examining the role of the
gut-lung axis in BPD.
Another important finding of our work is the demonstration
that neonatal commensal disruption produces pulmonary fibro-
sis. Although it is known that idiopathic pulmonary fibrosis
may be affected by the microbiome (25, 30), these experiments
are the first demonstration that intestinal commensal organisms
may play a role in fibrosis formation from hyperoxia-induced
lung injury. Pulmonary fibrosis is a classic component of
severe BPD (16), but it is less prevalent in modern postsurfac-
tant disease (15) because changes in clinical management have
led to a disease characterized by diffuse, milder injury. If
intestinal commensal ecology contributes to the development
of pulmonary fibrosis in preterm infants as our data suggest,
this finding could have significant implications for clinical
management. Our data suggest that antibiotic-induced com-
mensal disruption may increase the severity of BPD by pro-
moting pulmonary fibrosis and imply that by limiting perinatal
antibiotic exposure, we may be able to lower the prevalence of
clinically severe disease.
We also demonstrated that commensal disruption reduced
the pulmonary vasculature density. Lung injury inhibits the
function and maturation of the pulmonary vasculature (5), with
the most striking changes in the musculature of small arteries,
which lead to increased vascular resistance (35). A surprising
finding of these studies was that MAE not only potentiated a
reduction in the vascular density from hyperoxia, but that MAE
alone was sufficient to produce alterations in vascular devel-
opment even under normoxic conditions. Reduced pulmonary
vascular density is a critical characteristic of BPD that is linked
to the development of pulmonary hypertension, a severe com-
plication of chronic lung disease that markedly increases the
risk for mortality from BPD (36). The contribution of com-
mensal disruption to the development of pulmonary hyperten-
sion has profound implications for the mortality of BPD that
are worthy of further investigation and may play a role in the
progression of other pulmonary diseases as well. While our
data do not permit us to identify the cause of increased
mortality in our experiments, these findings could be related to
an increased prevalence of pulmonary hypertension.
Our data support a role of the intestinal microbiome in
experimental BPD and provide foundational evidence for a role
of the gut-lung axis in neonatal lung injury. We identified a
characteristic disruption in commensal ecology resulting from
MAE and demonstrated that this resulted in a more severe
phenotype of BPD characterized by increased mortality and
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pulmonary fibrosis as well as decreased pulmonary vascular
density. We identified alterations in microbial abundance with
biomarker and therapeutic potential, and mechanistically we
showed that these differences were associated with reduced
expression of IL-22 without differences in inflammasome ac-
tivation. Building on the differences highlighted by our prena-
tal and postnatal MAE exposure experiments, utilizing fecal
microbiota transfer or gnotobiotic mice may present an insight-
ful avenue for further research. Together, our findings establish
the importance of the intestinal commensal bacteria to the
development of BPD and provide insights for the rational
design of microbial-derived therapeutics for the most severe
pulmonary complication of prematurity.
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